Harman Finochem Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SUCCINYLCHOLINE CHLORIDE USP, with a corresponding US DMF Number 31986.
Remarkably, this DMF maintains an Active status since its submission on October 11, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 15, 2017, and payment made on October 06, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II